Jose C Florez joins us at the ADA annual meeting 2019 to discuss his presentation on diabetes research across the spectrum – from cell-based to clinical translation.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA
Questions:
1) What are the major obstacles to achieving personalised medicine in diabetes?
2) What is the role of epigenetic changes in the progression of type 1 and type 2 diabetes?
3) How will increased understanding of these changes affect the management of patients of diabetes?
4) What further research is needed to elucidate the genetic architecture of type 2 diabetes?
5) What recent advances in translational research in diabetes have excited you most?
